Literature DB >> 29372264

[Lichenoid drug reactions].

H F Merk1, L Vanstreels2, M Megahed2.   

Abstract

Lichenoid drug reactions are rare compared to typical morbilliform drug exanthema or urticaria. They are associated with specific drugs or drug families like gold, antimalarial drugs, β‑blockers and angiotensin-converting-enzyme inhibitors. Recent observations included associations with novel drugs such as biologics (e. g. tumour necrosis factor antagonists) and immune checkpoint inhibitors (anti-programme cell death protein 1 antibodies). Lichenoid drug reactions most often resemble lichen planus mainly in areas of ultraviolet-light exposed skin, but also mucosal lichen planus and even bullous lesions may occur.

Entities:  

Keywords:  Anti-PD-1 antibodies; Biosimilars; Gold; Interferons; TNF-α antagonists

Mesh:

Substances:

Year:  2018        PMID: 29372264     DOI: 10.1007/s00105-017-4117-y

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  30 in total

Review 1.  Lichen planus-like drug eruptions due to β-blockers: a case report and literature review.

Authors:  Chris Fessa; Penny Lim; Steve Kossard; Shawn Richards; Pablo Fernandez Peñas
Journal:  Am J Clin Dermatol       Date:  2012-12-01       Impact factor: 7.403

2.  Bullous lichen planus caused by labetalol.

Authors:  R W Gange; E W Jones
Journal:  Br Med J       Date:  1978-04-01

3.  MicroRNAs in cutaneous lichen planus.

Authors:  A A El-Rifaie; L A Rashed; R W Doss; S T Osman
Journal:  Clin Exp Dermatol       Date:  2017-09-22       Impact factor: 3.470

4.  Macrophage migration inhibition factor release in lichenoid drug eruptions.

Authors:  S Halevy; M Sandbank; E Livni
Journal:  J Am Acad Dermatol       Date:  1993-08       Impact factor: 11.527

Review 5.  Cutaneous Adverse Events of New Anti-melanoma Therapies: Classification and Management.

Authors:  S J E Hwang; R Anforth; G Carlos; P Fernandez-Peñas
Journal:  Actas Dermosifiliogr       Date:  2016-09-15

Review 6.  Lichen planus and other lichenoid dermatoses: Kids are not just little people.

Authors:  Michael J Payette; Gillian Weston; Stephen Humphrey; JiaDe Yu; Kristen E Holland
Journal:  Clin Dermatol       Date:  2015-09-12       Impact factor: 3.541

7.  IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade.

Authors:  Mark Ayers; Jared Lunceford; Michael Nebozhyn; Erin Murphy; Andrey Loboda; David R Kaufman; Andrew Albright; Jonathan D Cheng; S Peter Kang; Veena Shankaran; Sarina A Piha-Paul; Jennifer Yearley; Tanguy Y Seiwert; Antoni Ribas; Terrill K McClanahan
Journal:  J Clin Invest       Date:  2017-06-26       Impact factor: 14.808

Review 8.  Delayed cutaneous manifestations of drug hypersensitivity.

Authors:  Andreas J Bircher; Kathrin Scherer
Journal:  Med Clin North Am       Date:  2010-07       Impact factor: 5.456

9.  Antimalarial cutaneous side effects: a study in 209 users.

Authors:  Thelma Skare; Camila Ferrari Ribeiro; Fernanda H M Souza; Leticia Haendchen; Juliana Merheb Jordão
Journal:  Cutan Ocul Toxicol       Date:  2010-10-18       Impact factor: 1.820

10.  Terbinafine-induced lichenoid drug eruption.

Authors:  Yue Zheng; Jie Zhang; Haiyan Chen; Wei Lai; Howard I Maibach
Journal:  Cutan Ocul Toxicol       Date:  2016-03-30       Impact factor: 1.820

View more
  3 in total

Review 1.  Lesions in the oral cavity and esophagus caused by prescribed drugs: A review.

Authors:  Snezana Tesic-Rajkovic; Biljana Radovanovic-Dinic
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-11-05       Impact factor: 1.245

2.  Drug eruptions with novel targeted therapies - immune checkpoint and EGFR inhibitors.

Authors:  Isabella Pospischil; Wolfram Hoetzenecker
Journal:  J Dtsch Dermatol Ges       Date:  2021-11       Impact factor: 5.231

3.  Lichen planopilaris induced by infliximab: A case report.

Authors:  Meghan L McPhie; Ami Wang; Sonja Molin; Thomas Herzinger
Journal:  SAGE Open Med Case Rep       Date:  2020-01-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.